News Eli Lilly and Company Deutsche Boerse AG

Equities

LLY

US5324571083

Market Closed - Deutsche Boerse AG Other stock markets 08:48:49 17/05/2024 pm IST			5-day change	1st Jan Change
709.2 ^EUR	-0.70%		-0.44%	+34.70%

17/05	Roche: share price stands out, Deutsche Bank in support	CF
16/05	Health Care Flat as Momentum Wanes -- Health Care Roundup	DJ

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Roche: share price stands out, Deutsche Bank in support	17/05	CF
Health Care Flat as Momentum Wanes -- Health Care Roundup	17/05	DJ
Eli Lilly: research collaboration with Totus Medicines	16/05	CF
Eli Lilly: positive trials in type 2 diabetes	16/05	CF
Roche Shares Climb After Weight-Loss Drug Shows Efficacy in Early-Stage Trial -- Update	16/05	DJ
Totus Medicines Inc. Announces Strategic Multi-Target Research Collaboration with Eli Lilly and Company	16/05	CI
Eli Lilly's Once-Weekly Insulin Efsitora Alfa Meets Primary Endpoint in Late-Stage Studies	16/05	MT
Roche Gains as Weight-loss Injection Shows Potential in Early-stage Study	16/05	MT
Eli Lilly Says Once-Weekly Insulin Meets Key Goal in Two Studies	16/05	DJ
With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin	16/05	PR
Roche shares gain on obesity drug results from early-stage trial	16/05	RE
US Senate Committee Warns of Potential Healthcare Bankruptcy Due to Novo Nordisk's Wegovy	16/05	MT
Health Care Up on Momentum -- Health Care Roundup	16/05	DJ
UK weight-loss drug price rivalry intensifies with Pharmacy2U mark-down	15/05	RE
Eli Lilly Ethics/Compliance Chief Alonzo Weems to Retire	15/05	DJ
Eli Lilly: Alonzo Weems to retire at the end of the year	15/05	CF
Alonzo Weems to Retire as Executive Vice President of Enterprise Risk Management and Chief Ethics and Compliance Officer	15/05	PR
Eli Lilly and Company Announces Retirement of Alonzo Weems, Executive Vice President of Enterprise Risk Management and Chief Ethics and Compliance Officer, Effective December 31, 2024	15/05	CI
Eli Lilly: settlement agreement with Totality Medispa	15/05	CF
Ex-dividend day	15/05	FA

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 13, 2024 at 12:17 am IST